1. Home
  2. CRGX vs OLP Comparison

CRGX vs OLP Comparison

Compare CRGX & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • OLP
  • Stock Information
  • Founded
  • CRGX 2021
  • OLP 1982
  • Country
  • CRGX United States
  • OLP United States
  • Employees
  • CRGX N/A
  • OLP N/A
  • Industry
  • CRGX
  • OLP Real Estate Investment Trusts
  • Sector
  • CRGX
  • OLP Real Estate
  • Exchange
  • CRGX Nasdaq
  • OLP Nasdaq
  • Market Cap
  • CRGX 621.4M
  • OLP 622.6M
  • IPO Year
  • CRGX 2023
  • OLP N/A
  • Fundamental
  • Price
  • CRGX $11.18
  • OLP $25.54
  • Analyst Decision
  • CRGX Strong Buy
  • OLP Strong Buy
  • Analyst Count
  • CRGX 6
  • OLP 1
  • Target Price
  • CRGX $31.80
  • OLP $28.00
  • AVG Volume (30 Days)
  • CRGX 294.7K
  • OLP 70.7K
  • Earning Date
  • CRGX 11-12-2024
  • OLP 03-04-2025
  • Dividend Yield
  • CRGX N/A
  • OLP 7.02%
  • EPS Growth
  • CRGX N/A
  • OLP 51.11
  • EPS
  • CRGX N/A
  • OLP 1.63
  • Revenue
  • CRGX N/A
  • OLP $89,142,000.00
  • Revenue This Year
  • CRGX N/A
  • OLP N/A
  • Revenue Next Year
  • CRGX N/A
  • OLP $4.71
  • P/E Ratio
  • CRGX N/A
  • OLP $15.50
  • Revenue Growth
  • CRGX N/A
  • OLP N/A
  • 52 Week Low
  • CRGX $11.06
  • OLP $19.25
  • 52 Week High
  • CRGX $33.92
  • OLP $30.45
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 31.59
  • OLP 32.53
  • Support Level
  • CRGX $13.65
  • OLP $24.82
  • Resistance Level
  • CRGX $15.75
  • OLP $27.64
  • Average True Range (ATR)
  • CRGX 1.14
  • OLP 0.61
  • MACD
  • CRGX -0.16
  • OLP -0.18
  • Stochastic Oscillator
  • CRGX 5.30
  • OLP 25.53

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio of industrial, retail, restaurant, health and fitness, and theater properties. OLP owns hundred and ten properties, including three properties owned by consolidated joint ventures and two properties owned by unconsolidated joint ventures. The hundred and ten properties are located in thirty one states. The group generates the majority of its revenue in the form of rental income.

Share on Social Networks: